Characterization of the LOAEL-to-NOAEL Uncertainty Factor for Mild Adverse Effects from Acute Inhalation Exposures

Abdel-Rahman, 1995, Studies on the use of uncertainity factors in deriving RFDs, Hum. Ecolog. Risk Assess., 1, 614, 10.1080/10807039509380050 Alexeeff, 1997, Stochastic evaluation of acute inhalation thresholds from reported LOAELs [abstract No 851], Toxicologist, 36, 167 Alexeeff, G. V, Budroe, J. D, Collins, J. F, Lam, R. H. F, Lewis, D. X, Lipsett, M. J, Marty, M. A, and, Parker, T. R. 1999, Determination of Acute Reference Exposure Levels for Airborne Toxicants. Air Toxics Hotspots Program Risk Assessment Guidelines, Part I, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA. Aris, 1995, Methacholine responsiveness is not associated with O3-induced decreases in FEV1, Chest, 107, 621, 10.1378/chest.107.3.621 Bernstein, 1992, The relationship between airway responsiveness measured before and after the allergen-induced late asthmatic response, Chest, 101, 437, 10.1378/chest.101.2.437 Brand, 1999, Estimating noncancer uncertainty factors: Are ratios of NOAEL informative?, Risk Anal., 19, 295, 10.1111/j.1539-6924.1999.tb00406.x Carlson-Lynch, 1999, Application of quantitative information on the uncertainty in the RFD to noncarcinogenic risk assessments, Hum. Ecol. Risk Assess., 5, 527, 10.1080/10807039.1999.10518877 Cherniak, 1995, Physiologic diagnosis and function in asthma, Clin. Chest Med., 16, 567, 10.1016/S0272-5231(21)01164-3 Decisioneering, Incorporated, 1996, Crystal Ball Version 4.0, Decisioneering, Incorporated, Denver, CO. Dourson, 1983, Regulatory history and experimental support of uncertainty (safety) factors, Regul. Toxicol. Pharmacol., 3, 224, 10.1016/0273-2300(83)90030-2 Eiser, 1983, Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents [European Society for Clinical Respiratory Physiology Working Group “Bronchial hyperreactivity”], Bull. Eur. Physiopathol. Respir., 19, 495 Eschenbacher, 1992, Pulmonary responses of asthmatic and normal subjects to different temperature and humidity conditions in an environmental chamber, Lung, 170, 51, 10.1007/BF00164755 Gaylor, 1992, Incidence of developmental defects at the no observed adverse effect level (NOAEL), Regul. Toxicol. Pharmacol., 15, 151, 10.1016/0273-2300(92)90046-C Gift, 1993, Suitability of LOAEL-to-NOAEL 10-fold uncertainty factor for health assessments of inhaled toxicants [abstract], Toxicologist, 13, 140 Gold, W. G.1994. Pulmonary function testing. In Respiratory Medicine, 2nd ed. J. F. Murray and J. A. Nadel, Eds., pp. 815–817. Saunders, Philadelphia. Hays, 1988 Insightful Corporation, 2001, Getting Started with S-Plus 6 for Windows, Insightful Corporation, Seattle, WA. Jubber, 1993, Airway response to inhaled methacholine in normal human subjects, Pulm. Pharmacol., 6, 177, 10.1006/pulp.1993.1024 Leisenring, 1992, Statistical properties of the NOAEL, Regul. Toxicol. Pharmacol., 15, 161, 10.1016/0273-2300(92)90047-D 1993 1994 Price, 1997, An approach for modeling noncancer dose responses with an emphasis on uncertainty, Risk Anal., 17, 427, 10.1111/j.1539-6924.1997.tb00883.x (RAAC) Risk Assessment Advisory Committee, 1996, A review of the California Environmental Protection Agency's Risk Assessment Practices, Policies and Guidelines, Sacramento, CA. Sterk, 1993, Airway responsiveness: Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults [Report of Working Party, Standardization of Lung Function Tests, European Community for Steel and Coal], Eur. Resp. J., 6, 53, 10.1183/09041950.053s1693 Swartout, 1998, A probabilistic framework for the feference dose (Probabilistic RFD), Risk Anal., 18, 271, 10.1111/j.1539-6924.1998.tb01294.x (U.S. EPA) United States Environmental Protection Agency, 1994, Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F, Office of Research and Development, Washington, DC. Wiebicke, 1990, Comparison of the effects of inhaled corticosteroids on the airway response to histamine, methacholine, hyperventilation, and sulfur dioxide in subjects with asthma, J. Allergy Clin. Immunol., 86, 915, 10.1016/S0091-6749(05)80155-1 Woolcock, A. J.1994. Asthma. InRespiratory Medicine, 2nd ed. J. Murray and J. A. Nadel, Eds., pp. 1288–1330. Saunders, Philadelphia.